Literature DB >> 22488168

Clinical characteristics, sex hormones, and long-term follow-up in Swiss postmenopausal women presenting with Takotsubo cardiomyopathy.

Roman Brenner1, Daniel Weilenmann, Micha T Maeder, Lucas Jörg, Ina Bluzaite, Hans Rickli, Gabriella De Pasquale, Peter Ammann.   

Abstract

BACKGROUND: The overwhelming majority of patients with stress cardiomyopathy (SC) are postmenopausal women, suggesting an important pathophysiologic role of the female sex hormones. Preliminary data suggest that myocardial stunning might be provoked by estrogen deficiency. HYPOTHESIS: We hypothesized that, compared with age- and gender-matched patients with myocardial infarction (MI) or patients with normal coronary arteries, patients with SC would exhibit altered levels of sex hormones. Furthermore, we aimed to describe the clinical course and the pattern of sex hormones of the SC patients during long-term follow-up.
METHODS: Blood samples obtained on hospital admission were analyzed for estradiol (E2), progesterone (P), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in women with SC (n = 17), age-matched women with acute MI (n = 16), and women with normal coronary arteries (n = 15). Six years after the initial event, SC patients underwent a clinical and echocardiographic follow-up and reassessment of sex hormones.
RESULTS: Estrogen concentrations at hospital admission were significantly higher in the SC group compared with the MI and the control groups, with no difference in P, FSH, and LH concentrations. Follow-up E2 after 6 years in SC patients was lower than during the acute SC episode. Follow-up P in these patients was lower than P in the MI and control groups during the acute event, with a similar trend for E2. After a median follow-up of 6.4 years, 1 sudden cardiac death occurred and 2 patients suffered from SC recurrence.
CONCLUSIONS: During the acute event, E2 concentrations are elevated in postmenopausal SC patients compared with women with acute MI or with normal coronary arteries. The higher E2 concentrations might have exerted atheroprotective effects and thus diverted the stress response to SC rather than MI. Recurrence and/or sudden cardiac death remains a potential risk of SC.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488168      PMCID: PMC6652298          DOI: 10.1002/clc.21986

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  12 in total

1.  Reverse, or inverted, transient Takotsubo cardiomyopathy: terms and status of an open discussion.

Authors:  Paolo Angelini
Journal:  Tex Heart Inst J       Date:  2013

2.  Takotsubo Cardiomyopathy and Chronic Kidney Disease: A Scoping Study.

Authors:  Pramod Theetha Kariyanna; Panid Borhanjoo; Apoorva Jayarangaiah; Syed Haseeb; Aarti Shenoy; Sudhanva Hegde; Adam Budzikowski; Prabash Koneru; Rodaina Ahmed; Samy I McFarlane
Journal:  Scifed J Cardiol       Date:  2018-11-15

3.  Broken heart syndrome, neurogenic stunned myocardium and stroke.

Authors:  Amit S Dande; Amrita S Pandit
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-06

Review 4.  Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies.

Authors:  Hamayak Sisakian
Journal:  World J Cardiol       Date:  2014-06-26

5.  Stress-induced cardiomyopathy (Tako-Tsubo syndrome) in Austria.

Authors:  Valerie Weihs; Daniela Szücs; Barbara Fellner; Bernd Eber; Wolfgang Weihs; Thomas Lambert; Bernhard Metzler; Georg Titscher; Beate Hochmayer; Cornelia Dechant; Veronika Eder; Peter Siostrzonek; Franz Leisch; Max Pichler; Otmar Pachinger; Georg Gaul; Heinz Weber; Andrea Podczeck-Schweighofer; Hans-Joachim Nesser; Kurt Huber
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

Review 6.  Epidemiology and pathophysiology of Takotsubo syndrome.

Authors:  Yoshihiro J Akashi; Holger M Nef; Alexander R Lyon
Journal:  Nat Rev Cardiol       Date:  2015-04-07       Impact factor: 32.419

7.  Gender Differences in Patients with Takotsubo Cardiomyopathy: Multi-Center Registry from Tokyo CCU Network.

Authors:  Tsutomu Murakami; Tsutomu Yoshikawa; Yuichiro Maekawa; Tetsuro Ueda; Toshiaki Isogai; Konomi Sakata; Ken Nagao; Takeshi Yamamoto; Morimasa Takayama
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

8.  Analysis of the incidence and baseline predictors of the left ventricular ejection fraction returning to normal after dilated cardiomyopathy in postmenopausal women: a retrospective, observational study.

Authors:  Xiaopin Yuan; Shuai Mao; Qizhu Tang
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

Review 9.  Testosterone, cardiomyopathies, and heart failure: a narrative review.

Authors:  Rodica Diaconu; Ionuţ Donoiu; Oana Mirea; Tudor Adrian Bălşeanu
Journal:  Asian J Androl       Date:  2021 Jul-Aug       Impact factor: 3.285

Review 10.  Takotsubo syndrome: between evidence, myths, and misunderstandings.

Authors:  L Christian Napp; Johann Bauersachs
Journal:  Herz       Date:  2020-05       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.